Desjardins Cuts Andean Precious Metals (CVE:APM) Price Target to C$2.00

Andean Precious Metals (CVE:APM) had its price target trimmed by Desjardins from C$2.10 to C$2.00 in a report issued on Thursday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.

Andean Precious Metals Trading Up 7.5 %

Shares of CVE APM opened at C$1.29 on Thursday. Andean Precious Metals has a twelve month low of C$0.57 and a twelve month high of C$2.18. The company has a market capitalization of C$135.47 million, a price-to-earnings ratio of 2.55 and a beta of 1.22. The firm has a 50-day moving average of C$1.29 and a two-hundred day moving average of C$1.36.

Insider Activity at Andean Precious Metals

In other Andean Precious Metals news, Senior Officer Juan Carlos Sandoval Amare purchased 31,300 shares of the company’s stock in a transaction that occurred on Friday, January 3rd. The shares were purchased at an average cost of C$1.21 per share, with a total value of C$37,860.48. 69.37% of the stock is owned by insiders.

Andean Precious Metals Company Profile

Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.